SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wl9839 who wrote (700)3/20/2001 9:24:56 PM
From: wl9839  Read Replies (2) of 746
 
Celera Genomics Eyes Sales
Of Genome Data in Japan

Nikkei Net Interactive

TOKYO -- Celera Genomics Corp. hopes to sell data collected from its
successful sequencing of the human genome to Japanese pharmaceutical
companies and research centers, according to Craig Venter, president of the
U.S. biotechnology firm.

Mr. Venter said that the Japanese
government should sign a purchase contract
so that universities and other research
organizations involved in
government-sponsored biotechnology
projects can use the data to develop new drugs.

Takeda Chemical Industries Ltd. concluded a licensing contract with Celera in
March of last year. Takeda aimed to use the data to develop drugs tailored to
the needs of individual patients.

Asked about his company's business strategy following the completion of the
project to sequence the human genome, Mr. Venter said Celera will
emphasize developing techniques to diagnose cancer and other diseases in
their early stages through protein research.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News